Pfizer Licenses Medivation Alzheimer's Drug
Pfizer will pay $225 million up front to gain worldwide marketing rights to Dimebon. 2 months ago
TheStreet Click here to Read the Full StoryPfizer will pay $225 million up front to gain worldwide marketing rights to Dimebon. 2 months ago
TheStreet Click here to Read the Full Story
Digg
del.icio.us
Reddit
Stumble
Newsvine
Facebook